Macquarie Group
LCTX icon

Macquarie Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Macquarie Group’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,343
Closed -$8K – 2275
2017
Q4 		$8K Buy
+4,343
New +$8K ﹤0.01% 2309